Author Information
Gary J. Nabel is a prominent researcher affiliated with Sanofi, Cambridge, MA, USA. His work spans various fields, with a significant focus on developing vaccines and therapeutic antibodies. Nabel's extensive research contributions have established him as a leading figure in the field of nanotechnology and biomedicine.Research Contributions
Gary J. Nabel has made substantial contributions to the fields of virology, immunotherapy, and vaccine development. Key areas of his research include the development of bivalent EBV vaccines, trispecific HIV neutralizing antibodies, and HER2-targeting antibodies for breast cancer treatment. His studies have demonstrated potent anti-viral and anti-cancer activities, indicating promising therapeutic potential. Nabel's work also includes the development of a single-shot ChAd3-MARV GP vaccine for rapid and durable protection against Marburg virus, and adjuvanted influenza HA stem vaccines for broad neutralization of H1 and H3 viruses.Aliases
Gary J. Nabel is also known by several aliases, including Garyj. Nabel, G Nabel, G J Nabel, Gary J. Nabel, Gary J. Nabel'•̂, G. Nabel, Gary j. Nabel, G. J. Nabel, Gary Nabel, and Gary J Nabel.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
59,170 |
| H-Index |
134 |
| Paper Count |
581 |
